An Observational Study to Assess Disease Progression in Women With X-linked Adrenoleukodystrophy
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Observational, single-site prospective and minimally interventional study in women with X-linked adrenoleukodystrophy (ALD), conducted in France.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Women aged 18 years old or older.
• Diagnosis of X-linked ALD based on genetic testing, altered VLCFA levels, or family history.
• Willing to undergo annual follow-up visits, including brain and spinal cord MRI scans.
• Provision of written informed consent.
• Affiliation or beneficiary of a French social security system or of such a regime.
Locations
Other Locations
France
Paris Brain Institute (ICM) Centre Hospitalier Universitaire Pitié Salpêtrière
RECRUITING
Paris
Contact Information
Primary
Arun Mistry
amistry@minoryx.com
+34935441466
Time Frame
Start Date: 2024-01-02
Estimated Completion Date: 2027-06
Participants
Target number of participants: 40
Related Therapeutic Areas
Sponsors
Leads: Minoryx Therapeutics, S.L.